US A–BBB Joint Guarantee Callable Healthcare & Pharmaceuticals Corporate Bond Yields (USD)
Fitted spot curve as of 2026-07-28
https://bondscovery.com/yield-curve/usd-corporate-joint-guarantee-a-bbb-healthcare-pharmaceuticals-callable
US A–BBB Joint Guarantee Callable Healthcare & Pharmaceuticals Corporate Bond Yields (USD) as of 2026-07-28: 10Y at 5.52%, fitted curve 1M–40Y (4.67%–6.15%), 31 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 1M | 4.67% | — |
| 6M | 4.71% | 4.72% |
| 9M | 4.73% | 4.78% |
| 2Y | 4.85% | 4.92% |
| 3Y | 4.94% | 5.12% |
| 4Y | 5.03% | 5.31% |
| 5Y | 5.12% | 5.48% |
| 6Y | 5.21% | 5.64% |
| 8Y | 5.37% | 5.87% |
| 9Y | 5.45% | 6.06% |
| 10Y | 5.52% | 6.16% |
| 15Y | 5.80% | 6.36% |
| 25Y | 6.06% | 6.46% |
| 30Y | 6.11% | 6.35% |
| 40Y | 6.15% | 6.26% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 4.85% and the 10-year 5.52%, a 10Y−2Y spread of +67 bp — positively sloped — as of 2026-07-28. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-07-28 | 1m ago— | 2m ago2026-05-21 | 3m ago2026-05-14 |
|---|---|---|---|---|
| 2Y | 4.85% | — | 4.55% | 4.59% |
| 10Y | 5.52% | — | 5.26% | 5.22% |
| 10Y − 2Y | +67 bp | — | +71 bp | +63 bp |
Bonds in this curve
A selection of 30 of the 36 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Shire Acquisitions Investments Ireland DAC | 4.78% | 2026-09-23 | 3.20% | US82481LAD10 |
| Glaxosmithkline Capital | 4.24% | 2027-03-12 | 4.32% | US377373AM70 |
| CSL Finance PLC | 5.11% | 2027-04-27 | 3.85% | USG2584CAA48 |
| CSL Finance PLC | 4.43% | 2027-04-27 | 3.85% | US12661PAA75 |
| Glaxosmithkline Capital | 4.41% | 2028-05-15 | 3.88% | US377372AN70 |
| CSL Finance PLC | 5.05% | 2029-04-27 | 4.05% | USG2584CAB21 |
| CSL Finance PLC | 4.86% | 2029-04-27 | 4.05% | US12661PAB58 |
| Fresenius SE & CO Kgaa | 5.04% | 2029-06-15 | 3.75% | US35805BAA61 |
| Laboratory Corp of America Holdings | 5.00% | 2030-04-01 | 4.35% | US50540RAZ55 |
| Glaxosmithkline Capital | 4.72% | 2030-04-15 | 4.50% | US377372AP29 |
| Fresenius SE & CO Kgaa | 5.49% | 2031-02-16 | 2.38% | USU3149FAB59 |
| Fresenius SE & CO Kgaa | 5.44% | 2031-02-16 | 2.38% | US35805BAB45 |
| Laboratory Corp of America Holdings | 5.06% | 2032-04-01 | 4.55% | US50540RBA95 |
| CSL Finance PLC | 5.30% | 2032-04-27 | 4.25% | USG2584CAC04 |
| CSL Finance PLC | 5.10% | 2032-04-27 | 4.25% | US12661PAC32 |
| CSL Finance PLC | 5.20% | 2034-04-03 | 5.11% | US12661PAG46 |
| Laboratory Corp of America Holdings | 5.41% | 2034-10-01 | 4.80% | US50540RBB78 |
| Abbvie INC | 6.14% | 2035-03-15 | 4.55% | US00507UAT88 |
| Glaxosmithkline Capital | 5.27% | 2035-04-15 | 4.88% | US377372AQ02 |
| Takeda US Financing INC | 5.47% | 2035-07-07 | 5.20% | US87406BAA08 |
| Glaxosmithkline Capital | 5.47% | 2038-05-15 | 6.38% | US377372AE71 |
| CSL Finance PLC | 5.94% | 2042-04-27 | 4.62% | USG2584CAD86 |
| CSL Finance PLC | 5.97% | 2042-04-27 | 4.62% | US12661PAD15 |
| Glaxosmithkline Capital | 5.75% | 2043-03-18 | 4.20% | US377372AJ68 |
| CSL Finance PLC | 6.10% | 2052-04-27 | 4.75% | USG2584CAE69 |
| CSL Finance PLC | 6.01% | 2052-04-27 | 4.75% | US12661PAE97 |
| Alcon Finance Corp | 6.07% | 2052-12-06 | 5.75% | US01400EAF07 |
| CSL Finance PLC | 6.09% | 2054-04-03 | 5.42% | US12661PAH29 |
| Takeda US Financing INC | 6.08% | 2055-07-07 | 5.90% | US87406BAB80 |
| CSL Finance PLC | 6.15% | 2062-04-27 | 4.95% | US12661PAF62 |